Invités
Harry W. Flynn, Jr. MD
Yale L. Fisher, MD |
Animateur
John Chen |
1545 | Intravitreal injections and infection
Harry W. Flynn |
1600 | Discussion |
1605 | Intraocular foreign body management
Yale L. Fisher |
1620 | Discussion |
1625 | A novel pre-clinical model mimics the clinical features of reticular drusen disease (RDD) and the junctional zone of advancing non-exudative age-related macular degeneration (AMD)
Roxane Hillier, Xu Zhao, Hai Wang, Natalie Pankova, Shelley Boyd |
1630 | Discussion |
1632 | Intravitreal lucentis for the treatment of AMD related pigment epithelial detachment
Yiannis Iordanous, AnneMarie Powell, Alexander Mao, Philip L. Hooper, Carol Schwartz, Peter Kertes, Thomas Sheidow |
1637 | Discussion |
1639 | Choroidal neovascular membrane recurrence rate in wet AMD patients stable on three month ranibizumab dosing
Mark A. Mandell, Michael H. Brent |
1644 | Discussion |
1646 | Should paracenthesis be performed after intraocular Anti-VEGF injection?
Rani N. Al Karmi |
1651 | Discussion |
1653 | The effect of repeated topical fluoroquinolone use post intravitreal injection for neovascular Age-related Macular Degeneration (AMD) on ocular surface flora
Vivian Yin, Daniel Weisbord, Ken Eng, Efrem Mandelcorn, Radha Kohly, Carol Schwartz, Wai-Ching Lam, Andrew Simor, Peter Kertes |
1655 | Bacterial endophthalmitis: a ten-year review of the culture and sensitivity patterns of bacterial isolates
David Assaad, David Wong, Mikel Mikhail, Filiberto Altomare, Alan Berger, David Chow, Louis Giavedoni |
1700 | Discussion |
1702 | The use of OCT and autofluorescence in the diagnosis of early anti-malarial maculopathy
Michael Easterbrook, Michael H. Brent |
1707 | Discussion |